Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Dialysis | 6 | 2017 | 120 | 1.890 |
Why?
|
| Kidney Failure, Chronic | 10 | 2017 | 233 | 1.470 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2018 | 169 | 0.670 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 77 | 0.620 |
Why?
|
| Hypernatremia | 1 | 2017 | 10 | 0.590 |
Why?
|
| Electric Conductivity | 1 | 2017 | 51 | 0.590 |
Why?
|
| Population Groups | 2 | 2014 | 56 | 0.480 |
Why?
|
| Cardiovascular Diseases | 3 | 2018 | 664 | 0.480 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 61 | 0.460 |
Why?
|
| Appointments and Schedules | 2 | 2014 | 19 | 0.430 |
Why?
|
| Patient Compliance | 1 | 2014 | 212 | 0.420 |
Why?
|
| Glomerular Filtration Rate | 4 | 2008 | 139 | 0.410 |
Why?
|
| Heart Failure | 2 | 2007 | 235 | 0.400 |
Why?
|
| Aged | 15 | 2017 | 6741 | 0.390 |
Why?
|
| Kidney Diseases | 3 | 2008 | 167 | 0.320 |
Why?
|
| Treatment Refusal | 1 | 2008 | 20 | 0.320 |
Why?
|
| Coronary Disease | 2 | 2010 | 124 | 0.310 |
Why?
|
| Aged, 80 and over | 6 | 2017 | 2379 | 0.290 |
Why?
|
| Middle Aged | 16 | 2018 | 10129 | 0.270 |
Why?
|
| Referral and Consultation | 1 | 2005 | 117 | 0.250 |
Why?
|
| Troponin T | 1 | 2004 | 9 | 0.250 |
Why?
|
| Male | 17 | 2018 | 20025 | 0.240 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2003 | 5 | 0.230 |
Why?
|
| Retrospective Studies | 5 | 2014 | 2026 | 0.230 |
Why?
|
| Humans | 21 | 2018 | 37093 | 0.230 |
Why?
|
| Catheters, Indwelling | 1 | 2003 | 7 | 0.220 |
Why?
|
| Hyperkalemia | 1 | 2002 | 15 | 0.210 |
Why?
|
| Aspirin | 1 | 2003 | 49 | 0.210 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2003 | 62 | 0.210 |
Why?
|
| Diuretics | 1 | 2002 | 52 | 0.210 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 69 | 0.210 |
Why?
|
| Thrombosis | 1 | 2003 | 63 | 0.210 |
Why?
|
| Nephrosclerosis | 1 | 2002 | 6 | 0.210 |
Why?
|
| Warfarin | 1 | 2003 | 64 | 0.210 |
Why?
|
| Spironolactone | 1 | 2002 | 39 | 0.210 |
Why?
|
| Nephrotic Syndrome | 1 | 2002 | 10 | 0.200 |
Why?
|
| Hypertension, Renal | 1 | 2002 | 16 | 0.200 |
Why?
|
| Anticoagulants | 1 | 2003 | 102 | 0.200 |
Why?
|
| Proteinuria | 1 | 2002 | 50 | 0.200 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1067 | 0.200 |
Why?
|
| Adult | 12 | 2014 | 11712 | 0.190 |
Why?
|
| Female | 15 | 2014 | 20969 | 0.180 |
Why?
|
| Disease Progression | 2 | 2018 | 601 | 0.180 |
Why?
|
| Treatment Outcome | 3 | 2018 | 1369 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 7 | 0.150 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 105 | 0.150 |
Why?
|
| Vitamin D | 1 | 2018 | 196 | 0.140 |
Why?
|
| Hospitalization | 2 | 2014 | 388 | 0.130 |
Why?
|
| Mass Screening | 2 | 2010 | 462 | 0.130 |
Why?
|
| United States | 5 | 2018 | 4223 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 18 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2018 | 938 | 0.110 |
Why?
|
| Risk Factors | 5 | 2010 | 3562 | 0.100 |
Why?
|
| Time Factors | 2 | 2008 | 1742 | 0.100 |
Why?
|
| Prevalence | 3 | 2018 | 1455 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2008 | 1378 | 0.100 |
Why?
|
| Indians, North American | 1 | 2014 | 159 | 0.100 |
Why?
|
| Kidney Function Tests | 1 | 2010 | 29 | 0.100 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 127 | 0.090 |
Why?
|
| Community Networks | 2 | 2006 | 108 | 0.080 |
Why?
|
| Georgia | 2 | 2006 | 174 | 0.080 |
Why?
|
| Hypertension | 2 | 2006 | 796 | 0.080 |
Why?
|
| Infant, Low Birth Weight | 1 | 2007 | 39 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2008 | 455 | 0.070 |
Why?
|
| Anemia | 1 | 2007 | 45 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2008 | 242 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2006 | 66 | 0.070 |
Why?
|
| Comorbidity | 2 | 2005 | 623 | 0.070 |
Why?
|
| Registries | 2 | 2005 | 335 | 0.070 |
Why?
|
| Nephrology | 1 | 2005 | 17 | 0.070 |
Why?
|
| Unemployment | 1 | 2005 | 23 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 225 | 0.070 |
Why?
|
| Serum Albumin | 1 | 2005 | 50 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2005 | 104 | 0.060 |
Why?
|
| Stroke | 1 | 2008 | 286 | 0.060 |
Why?
|
| Coronary Angiography | 1 | 2004 | 90 | 0.060 |
Why?
|
| Educational Status | 1 | 2005 | 313 | 0.060 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2005 | 215 | 0.060 |
Why?
|
| Education, Medical | 1 | 2005 | 104 | 0.060 |
Why?
|
| Urban Population | 1 | 2005 | 333 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 400 | 0.060 |
Why?
|
| Sex Factors | 2 | 2007 | 898 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2003 | 11 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 219 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 198 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2003 | 61 | 0.050 |
Why?
|
| Alcoholism | 1 | 2005 | 240 | 0.050 |
Why?
|
| Poverty | 1 | 2005 | 348 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2002 | 64 | 0.050 |
Why?
|
| Creatinine | 1 | 2002 | 103 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 227 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 276 | 0.050 |
Why?
|
| Kidney Tubules | 1 | 2002 | 33 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 189 | 0.050 |
Why?
|
| Logistic Models | 1 | 2004 | 923 | 0.050 |
Why?
|
| Biopsy | 1 | 2002 | 164 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2002 | 325 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2002 | 84 | 0.050 |
Why?
|
| Minority Groups | 2 | 2005 | 596 | 0.050 |
Why?
|
| Length of Stay | 1 | 2002 | 185 | 0.050 |
Why?
|
| Health Promotion | 1 | 2006 | 653 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 560 | 0.040 |
Why?
|
| Kidney | 1 | 2002 | 337 | 0.040 |
Why?
|
| Early Diagnosis | 2 | 2010 | 64 | 0.040 |
Why?
|
| Incidence | 1 | 2002 | 922 | 0.040 |
Why?
|
| Prognosis | 1 | 2002 | 739 | 0.040 |
Why?
|
| Age Factors | 1 | 2002 | 1033 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2005 | 730 | 0.040 |
Why?
|
| Aging | 1 | 2002 | 664 | 0.040 |
Why?
|
| Health Surveys | 1 | 2018 | 373 | 0.040 |
Why?
|
| Adolescent | 2 | 2007 | 5363 | 0.030 |
Why?
|
| Community Health Services | 2 | 2008 | 185 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2008 | 484 | 0.030 |
Why?
|
| Primary Health Care | 2 | 2005 | 294 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2010 | 54 | 0.020 |
Why?
|
| Foundations | 1 | 2008 | 10 | 0.020 |
Why?
|
| Human Experimentation | 1 | 2008 | 11 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2008 | 291 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 104 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 583 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 54 | 0.020 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2007 | 894 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2005 | 100 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 191 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 138 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 646 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 284 | 0.010 |
Why?
|